Physiological Pacing for AV Block to Prevent Pacemaker-induced Cardiomyopathy
Physiological Pacing vs.Conventional Pacing in the Prevention of Pacemaker-induced Cardiomyopathy: A Randomized Study
Hospital Clinic of Barcelona
200 participants
Feb 1, 2022
INTERVENTIONAL
Conditions
Summary
The implantation of a pacemaker and conventional cardiac pacing from the right ventricle (apex or septum) is an effective and safe therapy for the treatment of patients with atrioventricular block and bradycardia.
Eligibility
Inclusion Criteria3
- The patient must be ≥ 18 years of age.
- The patient must indicate their acceptance to participate in the study by signing an informed consent document.
- Patients with EF\> 50% and indication for pacemaker implantation due to atrial-ventricular block according to current clinical guidelines.
Exclusion Criteria4
- Inability to understand and sign the informed consent.
- Patients with severe comorbidities and life expectancy \<1 year.
- Patients with severe cognitive impairment or other comorbidities resulting in dependence for basic activities of daily life.
- Patients who cannot come to our center to carry out the follow-up of the study.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients will have the pacemaker implanted in the electrophysiology laboratory. Electrode will be implanted (in the apical or septal portion) according to the criteria of the implanting physician.
Right ventricular lead was placed to get his bundle or left bundle branch.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05214365